Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: A longitudinal study

Lancet

Volumn 360, Issue 9345, 2002, Pages 1546-1551

  Sabin, Caroline A ^a   Griffioen, Anja ^a   Yee, Thynn Thynn ^a   Emery, Vincent C ^a   Herrero Martinez, Esteban ^a   Phillips, Andrew N ^a   Lee, Christine A ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN A; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DEATH; DISEASE COURSE; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FUNCTION; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEROCONVERSION;

EID: 0037121232     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11519-4     Document Type: Article

References (34)

1. Mellors J.W., Munoz A., Giorgi J.V., et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 126:1997;946-954.
2. Anastos K., Kalish L.A., Hessol N., et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. AIDS. 13:1999;1717-1726.
3. Kim S., Hughes M.D., Hammer S.M., Jackson J.B., De Gruttola V., Katzenstein D.A. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Res Hum Retrovir. 16:2000;645-653.
4. Miller V., Sabin C.A., Phillips A.N., et al. The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load. AIDS. 14:2000;2129-2136.
5. Phillips A.N., Sabin C.A., Elford J., Bofill M., Lee C.A., Janossy G. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS. 7:1993;975-980.
6. Sabin C.A., Phillips A.N., Lee C.A., et al. Beta-2 microglobulin as a predictor of prognosis in HIV-infected men with haemophilia: a proposed strategy for use in clinical care. Br J Haematol. 86:1994;366-374.
7. Multicohort Analysis Project Workshop. Part 1. Immunologic markers of AIDS progression: Consistency across five HIV-infected cohorts. AIDS 1994; 8: 911-21.
8. Kvale D., Aukrust P., Osnes K., Muller F., Froland S.S. CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predicts AIDS. AIDS. 13:1999;195-201.
9. Eyster M.E., Gail M.H., Ballard J.O., Al-Mondhiry H., Goedert J.J. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med. 107:1987;1-6.
10. Levy S., Geny A., Partisani M., Rey D., Lang J.M. Correlation between platelet number and viral load in HIV-1 infection. AIDS. 11:1997;1399-1400.
11. Feldman J.G., Burns D.N., Gange S.J., et al. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV Study. AIDS. 14:2000;863-870.
12. Phillips A., Shaper A.G., Whincup P.H. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1:1989;1434-1436.
13. Goldwasser P., Feldman J.G. Association of serum albumin and mortality risk. J Clin Epidemiol. 50:1997;693-703.
14. Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 55:1999;648-658.
15. Justice A.C., Feinstein A.R., Wells C.K. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med. 320:1989;1388-1393.
16. Khan M.H., Farrell G.C., Byth K., et al. Which patients with hepatitis C develop liver complications? Hepatology. 31:2000;513-520.
17. Eyster M.E., Diamondstone L.S., Lien J., Ehmann W.C., Quan S., Goedert J.J. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr. 6:1993;602-610.
18. Darby S.C., Ewart D.W., Giangrande P.L.F., et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet. 350:1997;1425-1431.
19. Yee T.T., Griffioen A., Sabin C.A., Dusheiko G., Lee C.A. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut. 47:2000;845-851.
20. Kernoff P.B.A., Lee C.A., Karayiannis P., Thomas H.C. High risk of non-A, non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol. 60:1985;469-479.
21. Lee C.A., Phillips A.N., Elford J., et al. The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol. 73:1989;228-2234.
22. Sabin C.A., Yee T.T., Devereux H., et al. Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy. AIDS. 14:2000;1001-1007.
23. Landau A., Batisse D., Piketty C., et al. Long-term efficacy of combination therapy with interferon-a2b and ribavirin for severe chronic hepatitis C in HIV-infected patients. AIDS. 15:2001;2149-2155.
24. Sabin C.A., Devereux H., Phillips A.N., et al. Course of viral load throughout HIV-1 infection. J Acquir Immune Defic Syndr. 23:2000;172-177.
25. Melchior J.-C., Niyongabo T., Henzel D., Durack-Brown I., Henri S.-C., Boulier A. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition. 15:1999;865-869.
26. Piroth L., Duong M., Quantin C., et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS. 12:1998;381-388.
27. Dorrucci M., Pezzotti P., Phillips A.N., Cozzi Lepri A., Rezza G. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. J Infect Dis. 172:1995;1503-1508.
28. Daar E.S., Lynn H., Donfield S., et al. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis. 183:2001;589-595.
29. Baum M.K., Shor-Posner G., Lu Y., et al. Micronutrients and HIV-1 disease progression. AIDS. 9:1995;1051-1056.
30. Gabay C., Kushner I. Acute-phase proteins and other systemic response to inflammation. N Engl J Med. 340:1999;448-454.
31. Blatt S.P., McCarthy W.F., Bucko-Krasnicka B., et al. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J Infect Dis. 171:1995;844-847.
32. Mocroft A., Kirk O., Barton S.E., et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS. 13:1999;943-950.
33. Hoover D.R., Peng Y., Saah A.J., Detels R.R., Rinaldo C.R., Phair J.P. Predicting disease when death is likely. Am J Epidemiol. 143:1996;943-952.
34. Prins M., Sabin C.A., Lee C.A., Devereux H., Coutinho R.A. Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men. AIDS. 14:2000;1829-1837.